Writing in Clinical Lab Products Magazine, Dr Jack Regan makes a strong case that diagnostic technology investment is key to preventing future pandemic diseases:
Diagnostics is an area that has been largely underfunded, despite the repeated and consistent warnings from virologists, microbiologists, epidemiologists, and other public health stakeholders. Years of underfunding diagnostics and inadequate testing policies have left us vulnerable to microbial attack, and SARS-CoV-2 has been just that sort of reckoning.
Even though we are not through fighting COVID-19, we must recognize that a similar threat will likely emerge in the not-too-distant future, and we must take steps now to prevent such a catastrophe.
Read more at Clinical Lab Products
